Statistics for Business and Economics

por Newbold, Paul, Carlson, William L, Thorne, Betty
Publicado 2007

Statistics for business and economics

por Newbold, Paul, Carlson, William L, Thorne, Betty
Publicado 2013

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases

por Sridhar, Sriram, Liu, Hao, Pham, Tuyet-Hang, Damera, Gautam, Newbold, Paul
Publicado 2019

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

por Jackson, David J., Humbert, Marc, Hirsch, Ian, Newbold, Paul, Garcia Gil, Esther
Publicado 2019

Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity

por Dagher, Rania, Kumar, Varsha, Copenhaver, Alan M., Gallagher, Sandra, Ghaedi, Mahboobe, Boyd, Jonathan, Newbold, Paul, Humbles, Alison A., Kolbeck, Roland
Publicado 2022

The relationship between airway immunoglobulin activity and eosinophils in COPD

por Southworth, Thomas, Higham, Andrew, Kolsum, Umme, Li, Jian, Scott, Thomas, Dungwa, Josiah, Sridhar, Sriram, Pham, Tuyet‐Hang, Newbold, Paul, Singh, Dave
Publicado 2020

A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

por Calverley, Peter M. A., Sethi, Sanjay, Dawson, Michelle, Ward, Christine K., Finch, Donna K., Penney, Mark, Newbold, Paul, van der Merwe, René
Publicado 2017

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

por Bleecker, Eugene R., Wechsler, Michael E., FitzGerald, J. Mark, Menzies-Gow, Andrew, Wu, Yanping, Hirsch, Ian, Goldman, Mitchell, Newbold, Paul, Zangrilli, James G.
Publicado 2018

Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker

por Rutten, Bert, Young, Simon, Rhedin, Magdalena, Olsson, Marita, Kurian, Nisha, Syed, Farhat, Beech, Augusta, Fidock, Mark, Newbold, Paul, Singh, Dave, Platt, Adam, Hughes, Glen
Publicado 2021

Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue

por Jogdand, Prajakta, Siddhuraj, Premkumar, Mori, Michiko, Sanden, Caroline, Jönsson, Jimmie, Walls, Andrew F., Kearley, Jennifer, Humbles, Alison A., Kolbeck, Roland, Bjermer, Leif, Newbold, Paul, Erjefält, Jonas S.
Publicado 2020

Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease

por Higham, Andrew, Beech, Augusta, Wolosianka, Sophie, Jackson, Natalie, Long, Gabriella, Kolsum, Umme, Southworth, Thomas, Pham, Tuyet‐Hang, Sridhar, Sriram, McCrae, Christopher, Newbold, Paul, Singh, Dave
Publicado 2020

Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab

por George, Leena, Wright, Adam, Mistry, Vijay, Sutcliffe, Amanda, Chachi, Latifa, Haldar, Koirobi, Ramsheh, Mohammadali Yavari, Richardson, Matthew, van der Merwe, René, Martin, Ubaldo, Newbold, Paul, Brightling, Christopher E
Publicado 2019

Detection of COPD Exacerbations and Compliance With Patient-Reported Daily Symptom Diaries Using a Smartphone-Based Information System

por Johnston, Neil W., Lambert, Kim, Hussack, Patricia, de Verdier, Maria Gerhardsson, Higenbottam, Tim, Lewis, Jonathan, Newbold, Paul, Jenkins, Martin, Norman, Geoffrey R., Coyle, Peter V., McIvor, R. Andrew
Publicado 2013

Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary Disease

por Bafadhel, M., McCormick, M., Saha, S., McKenna, S., Shelley, M., Hargadon, B., Mistry, V., Reid, C., Parker, D., Dodson, P., Jenkins, M., Lloyd, A., Rugman, P., Newbold, Paul, Brightling, C.E.
Publicado 2012

Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease

por Ghebre, Michael A., Bafadhel, Mona, Desai, Dhananjay, Cohen, Suzanne E., Newbold, Paul, Rapley, Laura, Woods, Jo, Rugman, Paul, Pavord, Ian D., Newby, Chris, Burton, Paul R., May, Richard D., Brightling, Chris E.
Publicado 2015

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup

por Diver, Sarah, Richardson, Matt, Haldar, Koirobi, Ghebre, Michael A., Ramsheh, Mohammadali Y., Bafadhel, Mona, Desai, Dhananjay, Cohen, Emma Suzanne, Newbold, Paul, Rapley, Laura, Rugman, Paul, Pavord, Ian D., May, Richard D., Barer, Michael, Brightling, Christopher.E.
Publicado 2019

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles

por Ghebre, Michael A., Pang, Pee Hwee, Diver, Sarah, Desai, Dhananjay, Bafadhel, Mona, Haldar, Koirobi, Kebadze, Tatiana, Cohen, Suzanne, Newbold, Paul, Rapley, Laura, Woods, Joanne, Rugman, Paul, Pavord, Ian D., Johnston, Sebastian L., Barer, Michael, May, Richard D., Brightling, Christopher E.
Publicado 2018